Kilitch Drugs (India) Ltd share price logo

Kilitch Drugs (India) Ltd Share Price

NSE: KILITCH

BSE: 524500

Small Cap

Healthcare Sector

₹379.50

+2.50

(+0.66%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Kilitch Drugs (India) Ltd Stock Performance

as on November 7, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹376.35
    ₹384.7
    downward going graph

    0.83%

    Downside

    1.37%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹294.07
    ₹500
    downward going graph

    22.51%

    Downside

    31.75%

    Upside

    downward going graph

Kilitch Drugs (India) Ltd share price movements today

Previous Close
₹377.00
Open
₹380.00
Volume
37.24K
Upper Circuit
₹452.40
Lower Circuit
₹301.60
Day's Low - High
₹376.35 - ₹384.7
52 Week Low - High
₹294.07 - ₹500

Kilitch Drugs (India) Ltd Historical Returns

1 Month Return
+ 5.05 %
3 Month Return
-14.72 %
1 Year Return
+ 25.77 %
3 Year Return
+ 120 %
5 Year Return
+ 298.22 %

Kilitch Drugs (India) Ltd Fundamentals

as on November 7, 2025 at 4:01 pm IST

Market Cap

₹663.40 Cr

Return on Equity (ROE)

11.02

PE Ratio (TTM)

22.26

Return on capital employed (ROCE)

13.14

Industry PE ratio

41.8

Beta (LTM)

0.74

P/B Ratio

2.3

Dividend Yield

0

PEG Ratio

2.38

Quarterly Earnings Growth YOY

1954.55

EPS (TTM)

15.178352987229

Sector

Pharmaceuticals

Book Value

123.12

Technical Analysis

Bullish

View Technical Analysis

Kilitch Drugs (India) Ltd Stock Valuation

as on November 7, 2025 at 4:01 pm IST

Kilitch Drugs (India) Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-986.00x)

July 3, 2019

Today (22.26x)

November 7, 2025

Industry (41.80x)

November 7, 2025

Highest (371.68x)

October 16, 2020

LowHigh

Today’s Price to Earnings Ratio: 22.26x

Kilitch Drugs (India) Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kilitch Drugs (India) Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Kilitch Drugs (India) Ltd image
Kilitch Drugs (India) Ltd
NA663.4059.64%0.6024198
Ortin Global Ltd image
Ortin Global Ltd
NA9.28-8.62%0.00-12
Aarey Drugs & Pharmaceuticals Ltd image
Aarey Drugs & Pharmaceuticals Ltd
NA275.7724.87%0.004473
Infinium Pharmachem Ltd image
Infinium Pharmachem Ltd
NA412.8051.69%0.697155
Astonea Labs Ltd image
Astonea Labs Ltd
NA168.073.58%0.00380
See all

Kilitch Drugs (India) Ltd Stock’s Investor Sentiment and Interest

Search interest for Kilitch Drugs (India) Ltd Stock has increased by 464% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:464% versus previous 30 day period

Kilitch Drugs (India) Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
29.97
45.48
36.56
41.2
31.79
44.82
33.45
47.47
56.17
61.23
43.14
Other Income
0.69
1.02
0.56
0.49
2.96
0.47
2.57
5.16
1.73
1.7
2.56
Total Income
30.66
46.5
37.12
41.69
34.75
45.29
36.03
52.64
57.89
62.92
45.7
Expenses
25.99
39.26
30.38
32.58
29.51
37.74
31.79
41.38
47.43
46.63
39.88
Operating Profit
3.98
6.22
6.18
8.62
2.28
7.08
1.66
6.09
8.74
14.6
3.26
Operating Profit Margin %
13.28%
13.68%
16.9%
20.92%
7.17%
15.8%
4.96%
12.83%
15.56%
23.84%
7.56%
Profit Before Interest, Tax and Depreciation
4.67
7.23
6.74
9.11
5.24
7.55
4.23
11.26
10.46
16.29
5.82
Interest
1.29
1.21
1.5
1.51
1.6
1.32
1.73
0.31
1.4
1.6
1.53
Depreciation
0.93
0.91
0.71
0.82
0.81
0.93
0.85
0.61
0.81
0.85
0.84
Profit Before Tax
2.45
5.11
4.53
6.78
2.83
5.3
1.65
10.34
8.25
13.84
3.45
Tax Paid
0.75
2.21
1.48
1.69
1.08
1.62
1.54
1.73
2.64
3.63
1.19
Profit After Tax
1.71
2.9
3.06
5.09
1.74
3.68
0.11
8.61
5.61
10.22
2.26
Total Net profit including share of profit / Loss from associate company
1.71
2.9
3.06
5.09
1.74
3.68
0.11
8.61
5.61
10.22
2.26
EPS
1.52
2.29
2.15
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88
Actual EPS
1.52
2.29
2.15
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88
Adjusted EPS
1.49
2.24
2.1
2.87
1.81
2.19
0.81
5.25
3.63
6.33
1.84
Diluted EPS
1.52
2.29
2.15
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88

Kilitch Drugs (India) Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
28.65
51.01
82.49
53.32
68.52
114.23
139.6
154.37
198.32
Other Income
1.14
2.88
4
4.13
2.67
2.91
2.92
4.48
11.16
Total Income
29.79
53.89
86.49
57.45
71.19
117.14
142.52
158.85
209.48
Expenses
29.35
45.73
75.48
53.12
63.33
103.87
122.03
130.22
166.85
Operating Profit
-0.7
5.28
7.01
0.2
5.19
10.36
17.57
24.15
31.47
Operating Profit Margin %
-2.44%
10.35%
8.5%
0.38%
7.57%
9.07%
12.59%
15.64%
15.87%
Profit Before Interest, Tax and Depreciation
0.44
8.16
11.02
4.32
7.86
13.28
20.48
28.63
42.63
Interest
-
-
0.38
0.72
0.75
1.2
4.92
5.93
5.04
Depreciation
9.76
2.04
2.05
2
1.99
2.47
3.55
3.35
3.11
Profit Before Tax
-9.32
6.12
8.59
1.6
5.12
9.61
12.01
19.35
34.48
Tax Paid
-0.43
0.96
4.76
0.77
1.36
3.4
3.73
5.78
9.53
Profit After Tax
-8.89
5.15
3.83
0.84
3.77
6.21
8.28
13.58
24.94
Total Net profit including share of profit / Loss from associate company
-8.89
5.15
3.83
0.84
3.77
6.21
8.28
13.58
24.94
EPS
-6.72
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
Actual EPS
-6.72
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
Adjusted EPS
-6.58
3.81
2.55
0.54
2.32
4.63
6.57
8.97
16.24
Diluted EPS
-6.72
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6

Kilitch Drugs (India) Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
17.23
1.12
1.42
0.29
4.46
45.66
5.78
2.59
-1.53
17.54
Cash Flow from Investing Activities
23.49
-1.54
-4.45
-13.98
-10.46
-37.57
-15.25
7.91
-8.15
-39.94
Cash Flow from Financing Activities
0.12
-0.04
5.51
16.85
0.85
1.61
7.03
-0.72
8.81
13.25
Net Cash Flow
-2.23
-0.45
2.48
3.17
-5.14
9.7
-2.44
9.78
-0.88
-9.16

Kilitch Drugs (India) Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
68.25%
68.25%
68.25%
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
63.77%
Public
31.75%
31.75%
31.75%
30.77%
30.77%
30.77%
30.77%
30.76%
30.77%
30.77%
30.76%
36.23%
Total Outstanding Shares
1,55,82,319
1,55,82,319
1,55,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,74,80,782
Total Shareholders
9,435
9,522
9,573
9,002
9,062
9,525
9,620
9,920
10,139
9,749
10,379
10,929

Kilitch Drugs (India) Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Kilitch Drugs (India) Ltd.

  • Kilitch Drugs (India) Ltd Earnings Results

    Kilitch Drugs (India) Ltd’s net profit jumped 126.12% since last year same period to ₹3.03Cr in the Q1 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -70.87% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Kilitch Drugs (India) Ltd Dividends May,2019

    In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 per share on 30 May 2019 - translating a dividend yield of 0.13%.

    Read More about Dividends

Insights on Kilitch Drugs (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 30.76% to 36.23% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, KILITCH has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, KILITCH has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 62.92 Cr → 45.7 Cr (in ₹), with an average decrease of 27.4% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 69.23% to 63.77% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 10.4 Cr → 3.03 Cr (in ₹), with an average decrease of 70.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, KILITCH stock has moved down by -14.3%

About Kilitch Drugs (India) Ltd

Kilitch Drugs India Ltd (KDIL) is a pharmaceutical company that was incorporated in May 1992 and has since gone public in Feb. 1994. They manufactures a range of pharmaceutical products including tablets, capsules, liquid orals, ointments, creams and injectables. They operate two divisions for OTC and ethical drugs, with additional manufacturing plants located in India, Ethiopia, Republic of Yemen and Patalganga Maharashtra, India. KDIL also provides exports for Sudan, Yemen, the Middle East, Miami and some South American countries. In 2011, they introduced a new product BENIN. In 2012, their undertakings located at Paonta Sahib in Himachal Pradesh were sold and transferred, while certain products were transferred to Akorn India Pvt. Ltd. KDIL's range of pharmaceutical services ensures safe and quality solutions for their customers.

Revenue: ₹43.14Cr as on June 2025 (Q1 FY26)
Net Profit: ₹2.26Cr as on June 2025 (Q1 FY26)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
OrganisationKilitch Drugs (India) Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOMukund P Mehta
E-voting on sharesClick here to vote

FAQs

What is Kilitch Drugs (India) Ltd share price today?

Kilitch Drugs (India) Ltd share price today stands at ₹379.5 as on at the close of the market. Kilitch Drugs (India) Ltd share today touched a day high of ₹384.7 and a low of ₹376.35.

What is the 52 week high and 52 week low range for Kilitch Drugs (India) Ltd share?

Kilitch Drugs (India) Ltd touched a 52 week high of ₹500 and a 52 week low of ₹294.07. Kilitch Drugs (India) Ltd share price today i.e. is closed at ₹379.5, which is -24.10% down from its 52 week high and 29.05% up from its 52 week low.

What is Kilitch Drugs (India) Ltd's market capitalisation today?

Kilitch Drugs (India) Ltd market capitalisation is ₹663.40 Cr as on .

How to buy Kilitch Drugs (India) Ltd shares?

To buy Kilitch Drugs (India) Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for KILITCH or Kilitch Drugs (India) Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Kilitch Drugs (India) Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Kilitch Drugs (India) Ltd trading volume today?

Kilitch Drugs (India) Ltd trading volume is 37.24K as on . This means that 37.24K shares of Kilitch Drugs (India) Ltd were bought and sold on the stock market during today's trading session.